Ahmedabad: Leading natural diamond company Shree Ramkrishna Exports has announced its entry into the pharmaceutical sector with the launch of Kriam Pharma.Speaking at the launch event in Surat, Tej Dholakia, founder of Kriam Pharma, said the venture aims to make medicines available at affordable prices, initially reaching 20,000 towns and villages across India.Kriam Pharma aims to supply medicines across the country by 2030, while creating more than 3,500 direct and indirect jobs, Dholakia said.The company is also exploring exports to emerging markets with high demand for dependable and high-quality medicines, he added.Kriam Pharma will focus on categories such as anti-diabetic, cardiac care, gastrointestinal, pain management, dermatological, vitamins and minerals, and anti-infectives.The company said it is currently sourcing its products from leading contract development and manufacturing organisations (CDMOs) and plans to set up in-house manufacturing in the second phase.Read also:Stryker expands RnD presence in India, opens new facility in Bengaluru
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!